Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) fell 16.7% during mid-day trading on Monday . The stock traded as low as GBX 2 ($0.03) and last traded at GBX 2 ($0.03). 3,174,548 shares traded hands during mid-day trading, an increase of 169% from the average session volume of 1,179,112 shares. The stock had previously closed at GBX 2.40 ($0.03).
Cizzle Biotechnology Stock Performance
The company has a market capitalization of £7.88 million, a price-to-earnings ratio of -2,790.96 and a beta of 0.38. The firm’s 50-day simple moving average is GBX 1.59 and its 200-day simple moving average is GBX 1.71.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The company reported GBX (0.60) (($0.01)) earnings per share (EPS) for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- Conference Calls and Individual Investors
- Apple’s Quiet HomePad Delay Could Be Its Loudest Move Yet
- What is Forex and How Does it Work?
- e.l.f. Gets Back on the Shelf! It’s Not Too Late to Buy In!
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a Look
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
